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During the past six decades, the importance of scientific research to the developed world and the 
daily lives of its citizens has led many 
indus trialized countries to rebrand them-
selves as ‘knowledge-based economies’. The 
increasing role of science as a main driver of 
innovation and economic growth has also 
changed the nature of research itself. Starting 
with the physical sciences, recent decades 
have seen academic research increasingly 
conducted in the form of large, expensive 
and colla borative ‘big science’ projects 
that often involve multidisciplinary, multi-
national teams of scientists, engineers and 
other experts.
Although laboratory biology was late to 
join the big science trend, there has never-
theless been a remarkable increase in the 
number, scope and complexity of research 
collaborations and projects involving bio-
logists over the past two decades (Parker 
et al, 2010). The Human Genome Project 
(HGP) is arguably the most well known of 
these and attracted serious scientific, pub-
lic and government attention to ‘big bio-
logy’. Initial exchanges were polarized 
and often polemic, as proponents of the 
HGP applauded the advent of big biology 
and argued that it would produce results 
un attainable through other means (Hood, 
1990). Critics highlighted the negative 
consequences of massive-scale research, 
including the industrialization, bureauc-
ratization and politicization of research 
(Rechsteiner, 1990). They also suggested that 
it was not suited to generating knowledge at 
all; Nobel laureate Sydney Brenner joked 
that sequencing was so boring it should be 
done by prisoners: “the more heinous the 
crime, the bigger the chromosome they 
would have to decipher” (Roberts, 2001).
A recent Opinion in EMBO reports sum-
marized the arguments against “the creep-
ing hegemony” of ‘big science’ over ‘little 
science’ in biomedical research. First, many 
large research projects are of questionable 
scientific and practical value. Second, big 
science transfers the control of research 
topics and goals to bureaucrats, when deci-
sions about research should be primarily 
driven by the scientific community (Petsko, 
2009). Gregory Petsko makes a valid point 
in his Opinion about wasteful research 
projects and raises the important question 
of how research goals should be set and 
by whom. Here, we contextualize Petsko’s 
arguments by drawing on the history and 
sociology of science to expound the draw-
backs and benefits of big science. We 
then advance an alternative to the current 
antipodes of ‘big’ and ‘little’ biology, which 
offers some of the benefits and avoids some 
of the adverse consequences.
Big science is not a recent develop-ment. Among the first large, colla-borative research projects were the 
Manhattan Project to develop the atomic 
bomb, and efforts to decipher German 
codes during the Second World War. The 
concept itself was put forward in 1961 by 
physicist Alvin Weinberg, and further deve-
loped by historian of science Derek De Solla 
Price in his pioneering book, Little Science, 
Big Science. “The large-scale character of 
modern science, new and shining and all 
powerful, is so apparent that the happy term 
‘Big Science’ has been coined to describe 
it” (De Solla Price, 1963). Weinberg noted 
that science had become ‘big’ in two ways. 
First, through the development of elaborate 
research instrumentation, the use of which 
requires large research teams, and second, 
through the explosive growth of scientific 
research in general. More recently, big 
science has come to refer to a diverse but 
strongly related set of changes in the organi-
zation of scientific research. This includes 
expensive equipment and large research 
teams, but also the increasing industriali-
zation of research activities, the escalating 
frequency of interdisciplinary and inter-
national collaborations, and the increas-
ing manpower needed to achieve research 
goals (Galison & Hevly, 1992). Many areas 
of biological research have shifted in these 
directions in recent years and have radically 
altered the methods by which biologists 
generate scientific knowledge.
Understanding the implications of this 
change begins with an appreciation of 
the history of collaborations in the life 
sciences—biology has long been a colla-
borative effort. Natural scientists accom-
panied the great explorers in the grand 
alliance between science and exploration 
during the sixteenth and seventeenth cen-
turies (Capshew & Rader, 1992), which not 
only served to map uncharted terri tories, 
but also contri buted enormously to know-
ledge of the fauna and flora disco vered. 
These early expe ditions gradually evolved 
into coordinated, multidisciplinary research 
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programmes, which began with the 
International Polar Years, intended to con-
centrate international research efforts at the 
North and South Poles (1882–1883; 1932–
1933). The Polar Years became exemplars 
of large-scale life science collaboration, 
begetting the International Geophysical 
Year (1957–1958) and the International 
Biological Programme (1968–1974).
Despite this long history of collabora-
tion, laboratory biology remained ‘small-
scale’ until the rising prominence of 
molecular biology changed the research 
landscape. During the late 1950s and 
early 1960s, many research organizations 
encouraged inter national collaboration 
in the life sciences, spurring the crea-
tion of, among other things, the European 
Molecular Biology Organization (1964) and 
the European Molecular Biology Laboratory 
(1974). In addition, inter national map-
ping and sequencing projects were deve-
loped around model organisms such as 
Drosophila and Caenorhabditis elegans, 
and scientists formed research networks, 
exchanged research materials and inform-
ation, and divided labour across labor-
atories. These new ways of working set 
the stage for the HGP, which is widely 
acknowledged as the cornerstone of the 
current ‘post-genomics era’. As an edito-
rial on ‘post-genomics cultures’ put it in the 
journal Nature, “Like it or not, big biology 
is here to stay” (Anon, 2001).
Just as big science is not new, neither are concerns about its consequences. As early as 1948, the sociologist Max Weber 
worried that as equipment was becom-
ing more expensive, scientists were losing 
autonomy and becoming more depen dent 
on external funding (Weber, 1948). 
Similarly, although Weinberg and De Solla 
Price expressed wonder at the scope of the 
changes they were witnessing, they too 
offered critical evaluations. For Weinberg, 
the potentially negative consequences asso-
ciated with big science were “adminstratitis, 
moneyitis, and journalitis”; meaning the 
dominance of science administrators over 
practitioners, the tendency to view funding 
increases as a panacea for solving scientific 
problems, and progressively blurry lines 
between scientific and popular writing in 
order to woo public support for big research 
projects (Weinberg, 1961). De Solla Price 
worried that the bureaucracy associated 
with big science would fail to entice the 
intellectual mavericks on which science 
depends (De Solla Price, 1963). These con-
cerns remain valid and have been voiced 
time and again.
As big science represents a major invest-
ment of time, money and manpower, it 
tends to determine and channel research 
in particular directions that afford certain 
possibilities and preclude others (Cook 
& Brown, 1999). In the worst case, this 
can result in entire scientific communities 
follow ing false leads, as was the case in the 
1940s and 1950s for Soviet agronomy. Huge 
investments were made to demonstrate the 
superiority of Lamarckian over Mendelian 
theories of heritability, which held back 
Russian biology for decades (Soyfer, 1994). 
Such worst-case scenarios are, however, 
rare. A more likely consequence is that 
big science can diminish the diversity of 
research approaches. For instance, plasma 
fusion scientists are now under pressure 
to design projects that are relevant to the 
large-scale International Thermonuclear 
Experimental Reactor, despite the poten-
tial benefits of a wide array of smaller-scale 
machines and approaches (Hackett et al, 
2004). Big science projects can also involve 
coordination challenges, take substantial 
time to realize success, and be difficult to 
evaluate (Neal et al, 2008).
Another danger of big science is that 
researchers will lose the intrinsic satis-
faction that arises from having personal 
control over their work. Dissatisfaction 
could lower research productivity (Babu 
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& Singh, 1998) and might create the con-
comitant danger of losing talented young 
researchers to other, more engaging call-
ings. Moreover, the alienation of sci-
entists from their work as a result of big 
science enterprises can lead to a loss of per-
sonal responsibility for research. In turn, 
this can increase the likelihood of miscon-
duct, as effective social control is eroded 
and “the satisfactions of science are over-
shadowed by organizational demands, eco-
nomic calculations, and career strategies” 
(Hackett, 1994).
Practicing scientists are aware of these risks. Yet, they remain engaged in large-scale projects because they 
must, but also because of the real benefits 
these projects offer. Importantly, big sci-
ence projects allow for the coordination 
and activation of diverse forms of expertise 
across disciplinary, national and profes-
sional boundaries to solve otherwise intrac-
table basic and applied problems. Although 
calling for international and inter discip-
linary collaboration is popular, practicing 
it is notably less popular and much harder 
(Weingart, 2000). Big science projects can 
act as a focal point that allows resear chers 
from diverse backgrounds to coope rate, and 
simultaneously advances different scientific 
specialties while forging interstitial connec-
tions among them. Another major benefit of 
big science is that it facilitates the develop-
ment of common research stan dards and 
metrics, allowing for the rapid development 
of nascent research frontiers (Fujimura, 
1996). Furthermore, the high profile of big 
science efforts such as the HGP and CERN 
draw public attention to science, poten-
tially enhancing scientific literacy and the 
public’s willingness to support research.
Big science can also ease some of the 
problems associated with scientific manage-
ment. In terms of training, graduate students 
and junior researchers involved in big sci-
ence projects can gain additional skills in 
problem-solving, communication and team 
working (Court & Morris, 1994). The bureau-
cratic structure and well-defined roles of 
big science projects also make leader ship 
transitions and researcher attrition easier to 
manage compared with the informal, refrac-
tory organization of most small research 
projects. Big science projects also provide 
a visible platform for resource acquisition 
and the recruitment of new scientific talent. 
Moreover, through their sheer size, diversity 
and complexity, they can also increase the 
frequency of serendipitous social interac-
tions and scientific discoveries (Hackett 
et al, 2008). Finally, large-scale research 
projects can influence scientific and public 
policy. Big science creates organizational 
structures in which many scientists share 
responsibility for, and expectations of, a 
scientific problem (Van Lente, 1993). This 
shared ownership and these shared futures 
help coordinate communication and enable 
researchers to present a united front when 
advancing the potential benefits of their 
projects to funding bodies. 
Given these benefits and pitfalls of big science, how might mole cular bio-logy best proceed? Petsko’s response 
is that, “[s]cientific priorities must, for the 
most part, be set by the free exchange of 
ideas in the scientific literature, at meetings 
and in review panels. They must be set from 
the bottom up, from the community of scien-
tists, not by the people who control the purse 
strings.” It is certainly the case, as Petsko also 
acknowledges, that science has benefited 
from a combination of generous public sup-
port and professional autonomy. However, 
we are less sanguine about his belief that the 
scientific community alone has the capacity 
to ascertain the practical value of particular 
lines of inquiry, determine the most appro-
priate scale of research, and bring them to 
fruition. In fact, current mismatches between 
the production of scientific knowledge and 
the infor mation needs of public policy-
 makers strongly suggest that the opposite is 
true (Sarewitz & Pielke, 2007).
Instead, we maintain that these types 
of decision should be determined through 
collective decision-making that involves 
researchers, governmental funding agen-
cies, science policy experts and the public. 
In fact, the highly successful HGP involved 
such collaborations (Lambright, 2002). 
Taking into account the opinions and atti-
tudes of these stakeholders better links 
knowledge production to the public good 
(Cash et al, 2003)—a major justification for 
supporting big biology. We do agree with 
Petsko, however, that large-scale projects 
can develop pathological characteristics, 
and that all programmes should therefore 
undergo regular assessments to determine 
their continuing worth.
Rather than arguing for or against big 
science, molecular biology would best 
benefit from strategic investments in a 
diverse port folio of big, little and ‘mezzo’ 
research projects. Their size, duration and 
organizational structure should be deter-
mined by the research question, subject 
matter and intended goals (Westfall, 2003). 
Parties involved in making these decisions 
should, in turn, aim at striking a profitable 
balance between differently sized research 
projects to garner the benefits of each and 
allow practitioners the autonomy to choose 
among them.
This will require new, innovative methods 
for supporting and coordinating research. An 
important first step is ensuring that funding 
is made available for all kinds of research at 
a range of scales. For this to happen, the cur-
rent funding model needs to be modified. 
The practice of allocating separate funds for 
individual investigator-driven and collec-
tive research projects is a positive step in the 
right direction, but it does not discriminate 
between projects of different sizes at a suf-
ficiently fine resolution. Instead, multiple 
funding pools should be made available for 
projects of different sizes and scales, allow-
ing for greater accuracy in project planning, 
funding and evaluation.
Second, science policy should cons-
ciously facilitate the ‘scaling up’, ‘scal-
ing down’ and concatenation of research 
projects when needed. For instance, special 
funds might be established for supporting 
small-scale but potentially transformative 
research with the capacity to be scaled up 
in the future. Alternatively, small-scale satel-
lite research projects that are more nimble, 
exploratory and risky, could complement 
big science initiatives or be generated by 
them. This is also in line with Petsko’s state-
ment that “the best kind of big science is 
the kind that supports and generates lots 
of good little science.” Another potentially 
fruitful strategy we suggest would be to fund 
Rather than arguing for or 
against big science, molecular 
biology would best benefit from 
strategic investments in a diverse 
portfolio of big, little and ‘mezzo’ 
research projects
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that ‘bigness’ has to offer, while 
avoiding the pitfalls inherent in 
doing so
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independent, small-scale research projects 
to work on co-relevant research with the later 
objective of consolidating them into a single 
project in a kind of building-block assem-
bly. By using these and other mechanisms 
for organizing research at different scales, it 
could help to ameliorate some of the prob-
lems associated with big science, while also 
accruing its most important benefits.
Within the life sciences, the field of ecology perhaps best exemp lifies this strategy. Although it encom-
passes many small-scale laboratory and 
field studies, ecologists now collaborate in a 
variety of novel organizations that blend ele-
ments of big, little and mezzo science and 
that are designed to catalyse different forms 
of research. For example, the US National 
Center for Ecological Analysis and Synthesis 
brings together researchers and data from 
many smaller projects to synthesize their 
findings. The Long Term Ecological Research 
Network consists of dozens of mezzo-scale 
collaborations focused on specific sites, but 
also leverages big science through cross-
site collaborations. While investments are 
made in classical big science projects, such 
as the National Ecological Observatory 
Network, no one project or approach has 
dominated—nor should it. In these ways, 
ecologists have been able to reap the ben-
efits of big science whilst maintaining 
diverse research approaches and individ-
ual autonomy and still being able to enjoy 
the intrinsic satisfaction associated with 
scientific work.
Big biology is here to stay and is neither 
a curse nor a blessing. It is up to scientists 
and policy-makers to discern how to bene-
fit from the advantages that ‘bigness’ has 
to offer, while avoiding the pitfalls inhe-
rent in so doing. The challenge confronting 
mole cular biology in the coming years is 
to decide which kind of research projects 
are best suited to getting the job done. 
Molecular biology itself arose, in part, 
from the migration of physicists to biology; 
as physics research projects and collabo-
rations grew and became more dependent 
on expensive equipment, appreciating the 
saliency of one’s own work became increas-
ingly difficult, which led some to seek ref-
uge in the comparatively little science of 
biology (Dev, 1990). The current situation, 
which Petsko criticizes in his Opinion arti-
cle, is thus the result of an organizational 
and intellectual cycle that began more than 
six decades ago. It would certainly behoove 
molecular bio logists to heed his warnings 
and consider the best paths forward.
REFERENCES
Anon (2001) Post-genomic cultures. Nature 409: 
545
Babu AR, Singh YP (1998) Determinants of 
research productivity. Scientometrics 43: 
309–329
Capshew JH, Rader KA (1992) Big science: Price 
to the present. Osiris 7: 3–25
Cash DW, Clack WC, Alcock F, Dickson NM, 
Eckley N, Guston DH, Jager J, Mitchel RB (2003) 
Knowledge systems for sustainable development. 
Proc Natl Acad Sci USA 100: 8086–8091
Cook SDN, Brown JS (1999) Bridging 
epistemologies: the generative dance between 
organizational knowledge and organizational 
knowing. Organization Sci 10: 381–400
Court G, Morris S (1994) The Training Benefits 
of Big Science. Brighton, UK: Institute for 
Employment Studies
De Solla Price DJ (1963) Little Science, Big 
Science. New York, NY, USA: Columbia 
University Press
Dev SB (1990) Migration of physical scientists to 
molecular biology and its impact. Interdiscip  
Sci Rev 15: 45–56
Fujimura J (1996) Crafting Science: A Sociohistory 
of the Quest for the Genetics of Cancer. 
Cambridge, MA, USA: Harvard University Press
Galison P, Hevly B (1992) Big Science: The 
Growth of Large-scale Research. Stanford, CA, 
USA: Stanford University Press
Hackett EJ (1994) A social control perspective 
on scientific misconduct. J Higher Educ 65: 
242–260
Hackett EJ, Conz D, Parker JN, Bashford J,  
DeLay S (2004) Tokamaks and turbulence: 
research ensembles, policy and technoscientific 
work. Res Policy 33: 747–767
Hackett EJ, Parker JN, Conz D, Rhoten D,  
Parker A (2008) Ecology transformed: NCEAS 
and changing patterns of ecological research. In 
G Olson et al (Eds), Scientific Collaboration on 
the Internet pp 277–296. Cambridge, MA, USA: 
MIT Press
Hood L (1990) No: and anyway, the HGP isn’t  
'Big Science'. The Scientist 4: 13
Lambright WH (2002) Managing “Big Science”: 
A Case Study of the Human Genome Project. 
Washington, DC, USA: Pricewaterhouse-
Coopers Endowment for the Business of 
Government
Neal HA, Smith TL, McCormick JB (2008) Beyond 
Sputnik: Science Policy in the 21st Century. Ann 
Arbor, MI, USA: University of Michigan Press
Parker JN, Vermeulen N, Penders B (2010) 
Collaboration in the New Life Sciences.  
London, UK: Ashgate
Petsko G (2009) Big science, little science.  
EMBO Rep 10: 1282
Rechsteiner M (1990) The Human Genome 
Project: two points of view. FASEB J 4:  
2941–2942
Roberts L (2001) Controversial from the start. 
Science 291: 1182–1188
Sarewitz D, Pielke RA (2007) The neglected heart 
of science policy: reconciling supply of and 
demand for science. Environ Sci Policy 10:  
5–16
Soyfer V (1994) Lysenko and the Tragedy of Soviet 
Science. Rutgers, NJ, USA: Rutgers University 
Press
Van Lente H (1993) Promising Technology: 
Dynamics of Expectations in Technological 
Developments. Enschede, the Netherlands: 
Twente University
Weber M (1948) Science as a vocation. In  
Gerth H, Mills CW (Eds), From Max Weber: 
Essays in Sociology pp 77–128. Oxford, UK: 
Oxford University Press
Weinberg AM (1961) Impact of large-scale science 
on the United States: big science is here to stay, 
but we have yet to make the hard financial and 
educational choices it imposes. Science 134: 
161–164
Weingart P (2000) Interdisciplinarity: the 
paradoxical discourse. In Weingart P,  
Stehr N (Eds) Practising Interdisciplinarity  
pp 25–41. Toronto, Canada: University of 
Toronto Press
Westfall C (2003) Rethinking big science:  
modest, mezzo, grand science and the 
development of the Bevelac, 1971–1993.  
Isis 94: 30–56
Niki Vermeulen is at the Department of Social 
Studies of Science, University of Vienna, 
Austria, and Technopolis Group Austria. 
E-mail: niki.vermeulen@univie.ac.at  
John N. Parker [top right] is at the National 
Center for Ecological Analysis and Synthesis, 
Santa Barbara, CA, USA.  
Bart Penders [bottom] is at the Centre for 
Society & Genomics, and the Department 
of Philosophy & Science Studies at Radboud 
University Nijmegen, The Netherlands, and 
the Department of Health, Ethics & Society, 
Maastricht University, The Netherlands.
Received 16 December 2009; accepted 16 April 2010; 
published online 14 May 2010
EMBO reports (2010) 11, 420–423.  
doi:10.1038/embor.2010.67
